Pinnacle Associates LTD Heron Therapeutics, Inc. Transaction History

Pinnacle Associates LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 05, 2019	SELL	$16.93 - $26.22 $417,070 - $645,929	-24,635 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$23.15 - $28.34 $100,586 - $123,137	-4,345 Reduced 14.99%	24,635 $602,000
Q4 2018 Feb 05, 2019	SELL	$22.03 - $32.01 $21,148 - $30,729	-960 Reduced 3.21%	28,980 $752,000
Q3 2018 Nov 13, 2018	SELL	$30.0 - $40.85 $479,250 - $652,578	-15,975 Reduced 34.79%	29,940 $948,000
Q2 2018 Aug 08, 2018	BUY	$26.4 - $42.0 $59,532 - $94,710	2,255 Added 5.16%	45,915 $1.78 Million
Q1 2018 May 11, 2018	BUY	$18.43 - $28.8 $600,080 - $937,728	32,560 Added 293.33%	43,660 $1.21 Million
Q4 2017 Feb 12, 2018	BUY	$14.8 - $18.85 $164,280 - $209,235	11,100	11,100 $201,000

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $179M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

Stay updated on Pinnacle Associates LTD with notifications on news.